Arrowhead Research, the parent company of RNAi drugs startup Calando Pharmaceuticals, said that it has named Thomas Tombrello to its scientific advisory board.
Tombrello is chairman of the division of physics, mathematics, and astronomy at the California Institute of Technology. He is also the institute's technology assessment officer, Arrowhead said.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
